Skip to content
10-Q

Quarterly Report

APTALIS PHARMA INC

0001193125-12-052580

← back to feed
Filed
Feb 10, 2012 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2012 · Feb 10, 2012 100 sh
Capex Q1 2012 · Dec 31, 2011 $4.33M
Capex Q1 2012 · Dec 31, 2010 $1.14M
Operating Cash Flow Q1 2012 · Dec 31, 2011 $13.24M
Operating Cash Flow Q1 2012 · Dec 31, 2010 $3.7M
Long Term Debt Q1 2012 · Dec 31, 2011 $966.09M
Long Term Debt Q1 2012 · Sep 30, 2011 $968.43M
Short Term Debt Q1 2012 · Dec 31, 2011 $8.8M
Short Term Debt Q1 2012 · Sep 30, 2011 $8.51M
Cash And Equivalents Q1 2012 · Dec 31, 2011 $132.01M
Cash And Equivalents Q1 2012 · Sep 30, 2011 $126.51M
Cash And Equivalents Q1 2012 · Dec 31, 2010 $150.74M
Cash And Equivalents Q1 2012 · Sep 30, 2010 $161.5M
Stockholders Equity Q1 2012 · Dec 31, 2011 −$14.06M
Stockholders Equity Q1 2012 · Sep 30, 2011 −$27.37M
Stockholders Equity Q1 2012 · Dec 31, 2010 −$22.24M
Stockholders Equity Q1 2012 · Sep 30, 2010 −$21.03M
Current Liabilities Q1 2012 · Dec 31, 2011 $205.52M
Current Liabilities Q1 2012 · Sep 30, 2011 $177.65M
Total Liabilities Q1 2012 · Dec 31, 2011 $1.4B
Total Liabilities Q1 2012 · Sep 30, 2011 $1.29B
Current Assets Q1 2012 · Dec 31, 2011 $286.61M
Current Assets Q1 2012 · Sep 30, 2011 $272.32M
Total Assets Q1 2012 · Dec 31, 2011 $1.39B
Total Assets Q1 2012 · Sep 30, 2011 $1.26B
Sga Expense Q1 2012 · Dec 31, 2011 $33.27M
Sga Expense Q1 2012 · Dec 31, 2010 $25.17M
Net Income Q1 2012 · Dec 31, 2011 $20.08M
Net Income Q1 2012 · Dec 31, 2010 $1.45M
Operating Income Q1 2012 · Dec 31, 2011 $41M
Operating Income Q1 2012 · Dec 31, 2010 $18.93M
Revenue Q1 2012 · Dec 31, 2011 $152.4M
Revenue Q1 2012 · Dec 31, 2010 $85.94M